Paul Denis Leger, MD, MPH, is a genitourinary medical oncologist at MedStar Georgetown University Hospital.

Leger specializes in cancers of the kidney, bladder, testicles, and prostate. Dr. Leger’s research focuses on innovative treatment of prostate cancer, especially metastatic prostate cancer; prostate cancer health disparity research (understanding the biologics behind why certain populations are at higher risk for prostate cancer); prostate cancer genomics; treatments to slow down disease progression in prostate cancer; and treatments to help address long-term side effects associated with hormone therapy. He also works with the GYN-ONC team for the medical management of gynecologic oncology patients, treating cancers of the cervix, ovaries, vulva, and uterus.

Leger received his medical degree from the State University of Haiti School of Medicine. Subsequently, he completed his residency in internal medicine at Vanderbilt University Medical Center and a fellowship in hematology oncology at National Institutes of Health.

MedStar Georgetown is part of the MedStar Georgetown Cancer Institute, which combines medical expertise, the latest therapies, and research across MedStar Health. Our research engine, the Georgetown Lombardi Comprehensive Cancer Center, is the only National Cancer Institute-designated comprehensive cancer center in the Washington, D.C., region. This partnership means we provide access to cutting-edge clinical trials and the latest breakthroughs in cancer care.